Lucid Diagnostics Inc

Research Lucid Diagnostics Inc (LUCD) on Bullrun: market cap USD 200.30M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLUCD
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 200.30M
• Financial periodFY2025
• RevenueUSD 4.71M
• Revenue growth8.3%
• Net income-USD 58.01M
• Free cash flow-USD 46.68M
• Gross margin-41.7%

Valuation Snapshot

latest market cap is USD 200.30M.

About Lucid Diagnostics Inc

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma.

Frequently asked questions

What is Lucid Diagnostics Inc's market cap?

Lucid Diagnostics Inc's market capitalization is USD 200.30M.

What does Lucid Diagnostics Inc do?

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma.